Disturbance of plasma melatonin profile by high dose melatonin administration inhibits testicular maturation of precocious male masu salmon.
We have previously shown that the testicular development of underyearling male masu salmon Oncorhynchus masou reared under a long photoperiod was accelerated by oral melatonin treatment (0.5 mg melatonin/kg body weight/day), suggesting that melatonin mediates photoperiodic signaling. In this study, we further examined the effects of a disturbance in the plasma melatonin profile on gonadal development in underyearling male masu salmon by administering a higher dose of melatonin. Fish randomly selected in June were divided into two groups. They were reared under a light:dark (LD) cycle of 16:8 (lights on 04:00-20:00 hr) and fed with pellets sprayed with melatonin or vehicle twice a day at 08:30 and at 15:30 hr (7.5 mg melatonin/kg body weight/day) until October. Fish were sampled on Day 0, 25, 60, 90 and 120. The plasma melatonin levels were high in the dark phase and low in the light phase in the control group, while they were constantly high with no significant change in the melatonin-treated group. Melatonin treatment had inhibitory effects on the gonadosomatic index and plasma testosterone levels. Pituitary salmon gonadotropin-releasing hormone content and luteinizing hormone content were significantly lower in the melatonin-treated group on Day 60 and 90, respectively. These results indicate that the plasma melatonin profile is important for mediating photoperiodic signals that regulate brain-pituitary-gonadal axis in underyearling precocious male masu salmon.
Amano
Masafumi
M
School of Fisheries Sciences, Kitasato University, Iwate, Japan. amanoma@kitasato-u.ac.jp
Iigo
Masayuki
M
Ikuta
Kazumasa
K
Kitamura
Shoji
S
Okuzawa
Koichi
K
Yamada
Hideaki
H
Yamamori
Kunio
K
D000704:Analysis of Variance; D000818:Animals; D007987:Gonadotropin-Releasing Hormone / Q000097:blood; D007564:Japan; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008550:Melatonin / Q000097:blood / Q000494:pharmacology*; D017683:Oncorhynchus / Q000254:growth & development*; D017440:Photoperiod; D012741:Sexual Maturation / Q000187:drug effects*; D013737:Testis / Q000254:growth & development*; D013739:Testosterone / Q000097:blood; D013997:Time Factors
D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D008550:Melatonin